Erleada 60 MG tablet UU 120S
Ended Awarded
- Contract number
- SPE2DB25FG8GD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,559
Award facts
- Contract value 100% obligated
- $7,558.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Erleada 60 mg tablets (120 count). This firm fixed price contract, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, demonstrates significant capability in fulfilling Defense Logistics Agency medical supply requirements through open competition. The company supplies an extensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support military healthcare systems and other government agencies. This particular delivery order for Erleada, a prostate cancer treatment, exemplifies the company's role in providing specialized pharmaceuticals to support military and veteran healthcare needs through the DLA's comprehensive pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DB25FG8GD?
SPE2DB25FG8GD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FG8GD worth?
The government has obligated $7,559 on SPE2DB25FG8GD.
Is contract SPE2DB25FG8GD an order under another contract?
Yes. SPE2DB25FG8GD is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FG8GD competed?
The extent of competition for SPE2DB25FG8GD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award